The PPAR γ target dataset contains Rosiglitazone (ZINC00968328); a thiazolidinedione that binds to PPAR receptors, and sensitises them to insulin.[39] It was sold under the trade name Avandia by GlaxoSmithKline though sales fell after a meta-study linked it to an increased risk of heart attack.[40] The virtual reactions with the Ullmann condensation reaction generated the molecular structure of Rosiglitazone as shown in Figure 10. This evidence concerns the gene INS and myocardial infarction.